Illumina Inc.: Empowering discoveries across omics

Cancer is a complex disease, and multiomic approach becomes key for driving next discoveries in this field. No single type of data can tell the whole story, but combining multiple layers gives us deeper insights and boosts discovery power. This is especially important in liquid biopsy research, where a multiomic perspective can reveal much more than any single approach alone.

In this session, we will be providing insights into most groundbreaking technologies enabling multiomic approach in research, with a special focus on liquid biopsy applications. Join us to discover innovative ways to gain deeper insights at the genomic, transcriptomic, proteomic, and epigenomic levels—and see how top researchers are using these advancements to better understand and tackle mechanisms of cancer more effectively.